Novo Nordisk
NVO
#110
Rank
โ‚น16.238 T
Marketcap
โ‚น3,684
Share price
-3.12%
Change (1 day)
-12.50%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

ESG Reports

Thumbnail Novo Nordisk ESG Report 2024

ESG Report 2024

Language: English

View ESG Report